03.01.2013
- The Western world's first drug to fix faulty genes promises to transform the lives of patients with an ultra-rare disease that clogs their blood with fat. The only snag is the...
19.10.2012
- AMRI announced today that it has entered into a multi-year supply agreement for an undisclosed product with Shire US Manufacturing, whose parent company, Shire, is a global company...
25.06.2012
- U.S. regulators have ruled against Shire in a battle over generic copies of its hyperactivity drug Adderall XR, approving a cut-price version of the medicine from Actavis, which is...
01.06.2012
- AstraZeneca's new chairman took the helm on Friday and said the troubled drugmaker faced "a period of significant change". Leif Johansson's first priority is to find a permanent...
27.04.2012
- Pharmaceutical firm Shire posted a 20% rise in first-quarter earnings on Thursday, just beating market expectations, as its drugs to treat hyperactivity again lifted market share...
22.12.2011
- GlaxoSmithKline executive German Pasteris is in charge of an Alzheimer's treatment that is years from reaching the market, if it ever does. But he already wants to make sure the...
14.06.2011
- Biotech deals in the $1 billion to $5 billion range are likely to be a sweet spot for drug companies looking to bolster their pipelines through M&A in an increasingly tough...
09.08.2010
- Paris-based drugmaker Sanofi-Aventis may need weeks of haggling to get a deal on buying U.S. biotech firm Genzyme as the two appear wide apart over price. Neither party has...
